Bajaj Hindusthan Sugar Limited has appointed Dr. Anil Rishiraj as an Additional Director (Non-Executive, Non-Independent Director) effective May 29, 2026. The Board of Directors approved the appointment based on the recommendation of the Nomination and Remuneration Committee. Dr. Rishiraj will hold office until the date of the next annual general meeting or the last date on which the annual general meeting should have been held, whichever is earlier.

Dr. Anil Rishiraj brings over 43 years of professional experience to the role. He has been working with Lalitpur Power Generation Company Limited since March 04, 2014. His career includes over 17 years as a Senior Management Executive with Large Corporate Groups, handling Business Development, Corporate Affairs, and Liaising & Networking at Higher Bureaucratic and Corporate Levels. Prior to this, he worked for over 26 years with Central Government Preventive & Investigative Departments under the Ministry of Finance. He has also been associated with Essar Services India Limited.

Dr. Rishiraj holds a Master of Arts Degree in Personnel Management & Industrial Relations, a Degree of Doctor of Social Work, and a Diploma in Human Resource Management. The company confirmed there are no relationships between Directors requiring disclosure. Additionally, Dr. Rishiraj is not debarred from holding the office of Director by virtue of any SEBI order or any other such authority.

The appointment was intimated to the exchanges under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The requisite details, including those required under SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, were submitted as part of the disclosure.

Key Details of Appointment

Bajaj Hindusthan Sugar Limited has scheduled its board meeting for Friday, May 29, 2026. The primary agenda is to consider and approve the audited financial results, both standalone and consolidated, for the financial year ended March 31, 2026.

Agenda for the Board Meeting

The Board of Directors will deliberate on several key financial documents and proposals. The meeting will focus on taking on record the Audited Financial Results (Standalone and Consolidated) for the financial year ended March 31, 2026. Additionally, the board will consider the Standalone and Consolidated Annual Financial Statements and the Auditors' Report thereon.

Other significant items on the agenda include the Board's Report, which encompasses the Management Discussion and Analysis Report, the Business Responsibility and Sustainability Report, and the Report on Corporate Governance. The board will also evaluate the recommendation of a dividend, if any, for the financial year ended March 31, 2026. Furthermore, the meeting will address the convening of the 94th Annual General Meeting of the shareholders of the company.

Audit Committee Meeting

Preceding the board meeting, the Audit Committee of Directors will convene on the same date. This committee meeting is scheduled to take place immediately prior to the board meeting to discuss and review the aforementioned audited financial results and the annual audited financial statements.

Trading Window Closure

In compliance with the company's "Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders," the trading window for designated persons remains closed. The window initially closed on April 01, 2026, and will continue to remain closed until 48 hours after the announcement of the audited financial results.